Form 4 for STE Steris
Accepted 2022-04-21 00:00:00 ET · period of report 2022-04-20 · accession 0001209191-22-025176 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-21 | 2022-04-20 | STE | Zangerle John Adam | SVP, Gen Counsel, Sec | M - OptEx | $67.98 | +8,000 | 39.0K | +26% | +$543.8K |
| D | 2022-04-21 | 2022-04-20 | STE | Zangerle John Adam | SVP, Gen Counsel, Sec | S - Sale+OE | $255.48 | -8,000 | 31.0K | -21% | -$2.04M |
| D | 2022-04-21 | 2022-04-20 | STE | Zangerle John Adam | SVP, Gen Counsel, Sec | M - OptEx | $0.00 | -8,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2022-04-20 | M | A | 8,000 | $67.98 | 39,023 | D | — | — | (F1) This exercise of stock options and sale of a total of 8,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on February 11, 2022. (F2) 14,064 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 6,138 on May 31, 2022; 1,504 on June 1, 2022; 819 on June 2, 2022; 202 on October 3, 2022; 834 on May 31, 2023; 752 on June 1, 2023; 819 on June 2, 2023; 202 on October 2, 2023; 752 on June 3, 2024; 819 on June 3, 2024; 202 on October 1, 2024; 819 on June 2, 2025; 202 on October 1, 2025. |
| 2 | Common | Ordinary Shares | 2022-04-20 | S | D | 8,000 | $255.48 | 31,023 | D | — | — | (F1) This exercise of stock options and sale of a total of 8,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on February 11, 2022. (F3) Price reflects a weighted average sale price for multiple transactions ranging from $255.48 to $255.54 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price. (F2) 14,064 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 6,138 on May 31, 2022; 1,504 on June 1, 2022; 819 on June 2, 2022; 202 on October 3, 2022; 834 on May 31, 2023; 752 on June 1, 2023; 819 on June 2, 2023; 202 on October 2, 2023; 752 on June 3, 2024; 819 on June 3, 2024; 202 on October 1, 2024; 819 on June 2, 2025; 202 on October 1, 2025. |
| 3 | Derivative | Employee Stock Option (right to buy) | 2022-04-20 | M | D | 8,000 | $0.00 | 0 | D | $67.98 · — to 2025-08-10 | 8,000 Ordinary Shares | (F1) This exercise of stock options and sale of a total of 8,000 ordinary shares is pursuant to a Rule 10b5-1 Stock Trading Plan entered into by the Reporting Person on February 11, 2022. (F4) This option to purchase 8,000 STERIS ordinary shares, which is fully vested, was received in conjunction with the Redomiciliation of the entity organized under the laws of the U.K. and formerly named STERIS plc ("Old STERIS") in exchange for an option to purchase 8,000 Old STERIS ordinary shares for $67.98 per share, subject to the same terms and conditions as the original Old STERIS stock option, except as otherwise required by law. |